Literature DB >> 20395308

Detection of adduct on tyrosine 411 of albumin in humans poisoned by dichlorvos.

Bin Li1, Ivan Ricordel, Lawrence M Schopfer, Frédéric Baud, Bruno Mégarbane, Florian Nachon, Patrick Masson, Oksana Lockridge.   

Abstract

Studies in mice and guinea pigs have shown that albumin is a new biomarker of organophosphorus toxicant (OP) and nerve agent exposure. Our goal was to determine whether OP-labeled albumin could be detected in the blood of humans exposed to OP. Blood from four OP-exposed patients was prepared for mass spectrometry analysis by digesting 0.010 ml of serum with pepsin and purifying the labeled albumin peptide by offline high performance liquid chromatography. Dimethoxyphosphate-labeled tyrosine 411 was identified in albumin peptides VRY(411)TKKVPQVSTPTL and LVRY(411)TKKVPQVSTPTL from two patients who had attempted suicide with dichlorvos. The butyrylcholinesterase activity in these serum samples was inhibited 80%. A third patient whose serum BChE activity was inhibited 8% by accidental inhalation of dichlorvos had undetectable levels of adduct on albumin. A fourth patient whose BChE activity was inhibited 60% by exposure to chlorpyrifos had no detectable adduct on albumin. This is the first report to demonstrate the presence of OP-labeled albumin in human patients. It is concluded that tyrosine 411 of human albumin is covalently modified in the serum of humans poisoned by dichlorvos and that the modification is detectable by mass spectrometry. The special reactivity of tyrosine 411 with OP suggests that other proteins may also be modified on tyrosine. Identification of other OP-modified proteins may lead to an understanding of neurotoxic symptoms that appear long after the initial OP exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395308      PMCID: PMC2886864          DOI: 10.1093/toxsci/kfq117

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  44 in total

1.  Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase.

Authors:  A Fidder; A G Hulst; D Noort; R de Ruiter; M J van der Schans; H P Benschop; J P Langenberg
Journal:  Chem Res Toxicol       Date:  2002-04       Impact factor: 3.739

Review 2.  The potential for toxic effects of chronic, low-dose exposure to organophosphates.

Authors:  D E Ray; P G Richards
Journal:  Toxicol Lett       Date:  2001-03-31       Impact factor: 4.372

3.  Poisoning due to organophosphate insecticides. Acute and chronic manifestations.

Authors:  T Namba; C T Nolte; J Jackrel; D Grob
Journal:  Am J Med       Date:  1971-04       Impact factor: 4.965

4.  The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate.

Authors:  G E Means; H L Wu
Journal:  Arch Biochem Biophys       Date:  1979-05       Impact factor: 4.013

5.  Mice treated with chlorpyrifos or chlorpyrifos oxon have organophosphorylated tubulin in the brain and disrupted microtubule structures, suggesting a role for tubulin in neurotoxicity associated with exposure to organophosphorus agents.

Authors:  Wei Jiang; Ellen G Duysen; Heidi Hansen; Luda Shlyakhtenko; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2010-02-08       Impact factor: 4.849

Review 6.  Plasma cholinesterase variants and the anaesthetist.

Authors:  M Whittaker
Journal:  Anaesthesia       Date:  1980-02       Impact factor: 6.955

7.  Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs.

Authors:  P G Richards; M K Johnson; D E Ray
Journal:  Mol Pharmacol       Date:  2000-09       Impact factor: 4.436

8.  Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes.

Authors:  J Tang; Y Cao; R L Rose; A A Brimfield; D Dai; J A Goldstein; E Hodgson
Journal:  Drug Metab Dispos       Date:  2001-09       Impact factor: 3.922

9.  Neuropsychiatric evaluation in subjects chronically exposed to organophosphate pesticides.

Authors:  Rosane Maria Salvi; Diogo R Lara; Eduardo S Ghisolfi; Luis V Portela; Renato D Dias; Diogo O Souza
Journal:  Toxicol Sci       Date:  2003-04       Impact factor: 4.849

10.  Mass spectral characterization of organophosphate-labeled, tyrosine-containing peptides: characteristic mass fragments and a new binding motif for organophosphates.

Authors:  Lawrence M Schopfer; Hasmik Grigoryan; Bin Li; Florian Nachon; Patrick Masson; Oksana Lockridge
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-07-24       Impact factor: 3.205

View more
  14 in total

Review 1.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

2.  Development of diagnostics in the search for an explanation of aerotoxic syndrome.

Authors:  Lawrence M Schopfer; Clement E Furlong; Oksana Lockridge
Journal:  Anal Biochem       Date:  2010-05-04       Impact factor: 3.365

3.  An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.

Authors:  Brooke G Pantazides; Caroline M Watson; Melissa D Carter; Brian S Crow; Jonas W Perez; Thomas A Blake; Jerry D Thomas; Rudolph C Johnson
Journal:  Anal Bioanal Chem       Date:  2014-03-07       Impact factor: 4.142

4.  Monoclonal Antibody That Recognizes Diethoxyphosphotyrosine-Modified Proteins and Peptides Independent of Surrounding Amino Acids.

Authors:  Seda Onder; Alicia J Dafferner; Lawrence M Schopfer; Gaoping Xiao; Udaya Yerramalla; Ozden Tacal; Thomas A Blake; Rudolph C Johnson; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2017-11-28       Impact factor: 3.739

5.  Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis.

Authors:  Eugénie Carletti; Lawrence M Schopfer; Jacques-Philippe Colletier; Marie-Thérèse Froment; Florian Nachon; Martin Weik; Oksana Lockridge; Patrick Masson
Journal:  Chem Res Toxicol       Date:  2011-04-18       Impact factor: 3.739

6.  Screening of monoclonal antibodies against specific phosphonylation sites and analysis of serum samples exposed to soman and VX using an indirect competitive enzyme-linked immunosorbent assay.

Authors:  Qiao Lv; Hui-Lan Yu; Yang Yang; Fan-Hua Meng; Xian-Dong Dai; Pei-Yu Jiang; Chang-Cai Liu
Journal:  Anal Bioanal Chem       Date:  2022-01-26       Impact factor: 4.142

7.  Polyclonal antibody to soman-tyrosine.

Authors:  Bin Li; Ellen G Duysen; Marie-Thérèse Froment; Patrick Masson; Florian Nachon; Wei Jiang; Lawrence M Schopfer; Geoffrey M Thiele; Lynell W Klassen; John Cashman; Gareth R Williams; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2013-03-21       Impact factor: 3.739

8.  PHOS-select iron affinity beads enrich peptides for the detection of organophosphorus adducts on albumin.

Authors:  Wei Jiang; Yaroslav A Dubrovskii; Ekaterina P Podolskaya; Ekaterina A Murashko; Vladimir Babakov; Florian Nachon; Patrick Masson; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Res Toxicol       Date:  2013-11-14       Impact factor: 3.739

9.  Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.

Authors:  Sigeng Chen; Jun Zhang; Lucille Lumley; John R Cashman
Journal:  J Pharmacol Exp Ther       Date:  2012-11-28       Impact factor: 4.030

10.  Protein tyrosine adduct in humans self-poisoned by chlorpyrifos.

Authors:  Bin Li; Peter Eyer; Michael Eddleston; Wei Jiang; Lawrence M Schopfer; Oksana Lockridge
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.